Primary |
Drug Use For Unknown Indication |
29.9% |
Atrial Fibrillation |
26.4% |
Product Used For Unknown Indication |
13.9% |
Cardiac Failure |
7.3% |
Hypertension |
5.6% |
Arrhythmia |
3.4% |
Congestive Cardiomyopathy |
1.6% |
Cardiac Disorder |
1.3% |
Type 2 Diabetes Mellitus |
1.3% |
Hypothyroidism |
1.1% |
Myocardial Ischaemia |
1.1% |
Angina Pectoris |
1.0% |
Essential Hypertension |
1.0% |
Prophylaxis |
1.0% |
Anticoagulant Therapy |
0.8% |
Cardiac Failure Congestive |
0.8% |
Supraventricular Tachycardia |
0.8% |
Chronic Obstructive Pulmonary Disease |
0.6% |
Diabetes Mellitus |
0.6% |
Heart Rate Irregular |
0.6% |
|
Vomiting |
15.7% |
Therapeutic Agent Toxicity |
15.2% |
Medication Error |
7.6% |
Death |
6.6% |
Nausea |
5.1% |
Syncope |
5.1% |
Overdose |
4.5% |
Product Quality Issue |
4.0% |
Visual Impairment |
4.0% |
Bradycardia |
3.5% |
Drug Ineffective |
3.5% |
Somnolence |
3.5% |
Cardioactive Drug Level Increased |
3.0% |
Toxicity To Various Agents |
3.0% |
Visual Disturbance |
3.0% |
Weight Decreased |
3.0% |
Heart Rate Increased |
2.5% |
Loss Of Consciousness |
2.5% |
Nodal Arrhythmia |
2.5% |
Completed Suicide |
2.0% |
|
Secondary |
Drug Use For Unknown Indication |
18.7% |
Depression |
13.9% |
Diabetes Mellitus |
12.0% |
Product Used For Unknown Indication |
9.9% |
Atrial Fibrillation |
8.8% |
Hypertension |
6.5% |
Tachyarrhythmia |
5.9% |
Cardiac Failure |
4.3% |
Dyslipidaemia |
2.4% |
Cardiac Failure Chronic |
2.1% |
High Density Lipoprotein Decreased |
2.1% |
Cardiac Failure Congestive |
1.8% |
Rheumatoid Arthritis |
1.8% |
Cardiac Disorder |
1.7% |
Ill-defined Disorder |
1.6% |
Hypothyroidism |
1.4% |
Arrhythmia |
1.3% |
Cardiomyopathy |
1.3% |
Self Injurious Behaviour |
1.2% |
Type 2 Diabetes Mellitus |
1.2% |
|
Vomiting |
12.8% |
Death |
11.2% |
Myocardial Infarction |
11.2% |
Syncope |
8.0% |
Pneumonia |
5.6% |
Therapeutic Agent Toxicity |
5.6% |
Weight Decreased |
4.8% |
Bradycardia |
4.0% |
Overdose |
4.0% |
Dyspnoea |
3.2% |
Hyponatraemia |
3.2% |
Hypotension |
3.2% |
Renal Disorder |
3.2% |
Renal Failure Acute |
3.2% |
Respiratory Arrest |
3.2% |
Sinus Bradycardia |
3.2% |
Toxicity To Various Agents |
3.2% |
Cardiac Failure Congestive |
2.4% |
Dizziness |
2.4% |
Drug Exposure During Pregnancy |
2.4% |
|
Concomitant |
Product Used For Unknown Indication |
30.1% |
Drug Use For Unknown Indication |
20.2% |
Atrial Fibrillation |
10.0% |
Hypertension |
7.4% |
Cardiac Disorder |
3.8% |
Diabetes Mellitus |
3.3% |
Pain |
2.9% |
Cardiac Failure Congestive |
2.1% |
Rheumatoid Arthritis |
2.1% |
Pulmonary Arterial Hypertension |
1.9% |
Depression |
1.8% |
Osteoporosis |
1.8% |
Type 2 Diabetes Mellitus |
1.7% |
Blood Cholesterol Increased |
1.7% |
Chronic Obstructive Pulmonary Disease |
1.7% |
Multiple Myeloma |
1.7% |
Cardiac Failure |
1.6% |
Hormone Replacement Therapy |
1.5% |
Prophylaxis |
1.4% |
Pulmonary Hypertension |
1.3% |
|
Vomiting |
11.9% |
Weight Decreased |
9.7% |
Death |
9.1% |
Myocardial Infarction |
8.1% |
Weight Increased |
6.3% |
Transient Ischaemic Attack |
5.1% |
Nausea |
4.7% |
Pain |
4.6% |
Oedema Peripheral |
4.4% |
Dyspnoea |
4.2% |
International Normalised Ratio Increased |
3.9% |
Urinary Tract Infection |
3.6% |
Vision Blurred |
3.6% |
Sepsis |
3.4% |
Pneumonia |
3.2% |
Renal Failure Acute |
3.1% |
Renal Failure |
2.9% |
Syncope |
2.8% |
Unevaluable Event |
2.8% |
Drug Ineffective |
2.6% |
|
Interacting |
Diabetes Mellitus |
23.4% |
Depression |
22.4% |
Tachyarrhythmia |
11.2% |
Atrial Fibrillation |
6.5% |
Dyslipidaemia |
5.6% |
Essential Hypertension |
5.6% |
High Density Lipoprotein Decreased |
5.6% |
Blood Cholesterol Increased |
3.7% |
Product Used For Unknown Indication |
3.7% |
Drug Use For Unknown Indication |
2.8% |
Angina Pectoris |
1.9% |
Hypercholesterolaemia |
1.9% |
Hypertensive Heart Disease |
1.9% |
Parkinson's Disease |
1.9% |
Hypokalaemia |
0.9% |
Palpitations |
0.9% |
|
Myocardial Infarction |
50.0% |
Drug Interaction |
16.7% |
Volume Blood Decreased |
16.7% |
Drug Ineffective |
8.3% |
Toxicity To Various Agents |
8.3% |
|